The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $31.15

Today's change-0.31 -0.99%
Updated January 24 4:01 PM EST. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $31.15

Today's change-0.31 -0.99%
Updated January 24 4:01 PM EST. Delayed by at least 15 minutes.

Pfizer Inc down (U.S.)$0.31

Pfizer Inc closed lower Tuesday, dropping (U.S.)$0.31 or 0.99% to (U.S.)$31.15. Shares have lost 2.84% over the last five days, but are unchanged over the last 52 weeks. This security has underperformed the S&P 500 by 18.14% during the last year.

Key company metrics

  • Open(U.S.) $31.40
  • Previous close(U.S.) $31.46
  • High(U.S.) $31.46
  • Low(U.S.) $30.90
  • Bid / Ask(U.S.) $31.15 / (U.S.) $31.23
  • YTD % change-4.09%
  • Volume29,624,466
  • Average volume (10-day)26,698,312
  • Average volume (1-month)24,172,268
  • Average volume (3-month)24,991,464
  • 52-week range(U.S.) $28.25 to (U.S.) $37.39
  • Beta0.93
  • Trailing P/E31.10×
  • P/E 1 year forward13.04×
  • Forward PEG1.91×
  • Indicated annual dividend(U.S.) $1.28
  • Dividend yield4.11%
  • Trailing EPS(U.S.) $1.00
Updated January 24 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.84%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 02, 201610/02/2016Jul 03, 201607/03/2016Apr 03, 201604/03/2016Dec 31, 201512/31/2015
Revenue13,04513,14713,00514,047
Total other revenue--------
Total revenue13,04513,14713,00514,047
Gross profit9,9639,97310,15410,675
Total cost of revenue3,0823,1742,8513,372
Total operating expense11,33810,5479,23414,079
Selling / general / administrative3,5593,4713,3855,048
Research & development1,8811,7481,7312,348
Depreciation / amortization9689611,006980
Interest expense (income), net operating--------
Unusual expense (income)2,1181,4535962,366
Other operating expenses, total-270-260-335-35
Operating income1,7072,6003,771-32
Interest income (expense), net non-operating-306-308-321-335
Gain (loss) on sale of assets473192
Other--------
Income before tax1,6042,4103,561-355
Income after tax1,3202,0353,026-167
Income tax, total284375535-188
Net income1,3202,0203,017-173
Total adjustments to net income-1-1-11
Net income before extra. items1,3202,0193,017-170
Minority interest0-16-9-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,3192,0183,016-169
Inc. avail. to common incl. extra. items1,3192,0193,016-172
Diluted net income1,3192,0193,016-172
Dilution adjustment000--
Diluted weighted average shares6,1386,1376,2146,176
Diluted EPS excluding extraordinary itemsvalue per share0.210.330.49-0.03
Dividends per sharevalue per share0.300.300.300.28
Diluted normalized EPSvalue per share0.540.550.600.34